Rx Industry Should Support Imports To Block Other Price Controls – Attorney
Drug manufacturers should support a legalized drug importation system because it is the most benign form of cost containment facing the industry, Mayer, Brown, Rowe & Maw Partner Alvin Lorman said
You may also be interested in...
The pharmaceutical industry's experience with parallel trade in Europe demonstrates that safety concerns should not prevent Rx importation in the U.S., according to a Pfizer exec
Drug manufacturers would be required to notify FDA of any manufacturing changes that might serve to circumvent reimportation under bipartisan legislation introduced by Sens. Byron Dorgan (D-N.D.) and Edward Kennedy (D-Mass.) April 21
Pharmaceutical companies should not market products in countries that do not allow "reasonable" prices for drugs, Genentech CEO Arthur Levinson declared during a March 12 investor conference